These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 5793351)

  • 1. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.
    Salti IS; Ruse JL; Stiefel M; Delarue NC; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):11-6. PubMed ID: 5793350
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension with inappropriate aldosterone stimulation.
    Christlieb AR; Hickler RB; Lauler DP; Williams GH
    N Engl J Med; 1969 Jul; 281(3):128-31. PubMed ID: 4307140
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension treatable with glucocorticoids: report of a case].
    Montero J; Fardella C; Mosso L
    Rev Med Chil; 1997 Nov; 125(11):1361-5. PubMed ID: 9609059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension].
    Rosset G
    Schweiz Med Wochenschr; 1973 Mar; 103(12):439-48. PubMed ID: 4697590
    [No Abstract]   [Full Text] [Related]  

  • 8. A German family with glucocorticoid-remediable aldosteronism.
    Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
    Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hypoaldosteronism caused by a probable anomaly of 18-hydroxylation].
    Jean R; Legrand JC; Meylan F; Rieu D; Astruc J
    Arch Fr Pediatr; 1969; 26(7):769-77. PubMed ID: 5355252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 11. A kindred with familial glucocorticoid suppressible aldosteronism.
    Giebink GS; Gotlin RW; Biglieri EG; Katz FH
    J Clin Endocrinol Metab; 1973 Apr; 36(4):715-23. PubMed ID: 4346813
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoid responsive aldosteronism: our pediatric cases and presentation of concepts].
    Igarashi Y; Imai M; Egi S; Kawato H; Suwa S
    Nihon Rinsho; 1971 Mar; 29(3):939-51. PubMed ID: 4324175
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of saline infusions on aldosterone secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism.
    Espiner EA; Tucci JR; Jagger PI; Lauler DP
    N Engl J Med; 1967 Jul; 277(1):1-7. PubMed ID: 6027294
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism.
    Litchfield WR; Coolidge C; Silva P; Lifton RP; Fallo F; Williams GH; Dluhy RG
    J Clin Endocrinol Metab; 1997 May; 82(5):1507-10. PubMed ID: 9141541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.